Cardiac Resynchronization Therapy Market To Reach USD 6.51 Billion By 2031, Driven By Expanding Clinical Adoption And Shift Toward Value-Based Care

(MENAFN- GetNews)

Explore the Cardiac resynchronization therapy market (2026–2031) with Mordor Intelligence. Get in-depth insights on market size, share, revenue, segments, key drivers, latest trends, and growth opportunities shaping the future of sustainable construction.

Cardiac Resynchronization Therapy Market Overview

The Cardiac resynchronization therapy market continues to show steady progress as healthcare systems focus on improving outcomes for patients with heart failure. According to industry analysis, the Cardiac resynchronization therapy market size was valued at USD 5.03 billion in 2025 and is estimated to grow from USD 5.25 billion in 2026 to reach USD 6.51 billion by 2031, registering a CAGR of 4.39% during the forecast period. This growth reflects consistent demand for device-based cardiac care and the growing importance of long-term disease management.

The Cardiac resynchronization therapy industry is shaped by the increasing burden of cardiovascular diseases and a broader shift toward therapies that reduce hospital readmissions. As healthcare providers move beyond procedure volume and focus more on patient outcomes, CRT devices are gaining importance as a reliable treatment option. The market is also benefiting from improvements in diagnostic tools that identify eligible patients earlier, supporting sustained demand across regions.

Access the complete data-driven outlook on the Cardiac resynchronization therapy Market now -

Cardiac Resynchronization Therapy Market Trends

Rising Heart Failure Burden

One of the most important Cardiac resynchronization therapy market trends is the growing number of patients diagnosed with heart failure. With lifestyle changes, aging populations, and increasing cardiovascular risk factors, more patients require advanced device-based therapies. CRT devices help improve heart function and reduce hospitalizations, making them a preferred option in clinical practice.

Growing Aging Population

The expanding elderly population is another major factor influencing Cardiac resynchronization therapy market growth. Older adults are more likely to experience cardiac conditions that require rhythm management. This demographic trend is particularly strong in developing regions, where healthcare access is improving and treatment adoption is increasing.

Shift Toward Value-Based Care

Healthcare providers are focusing more on cost efficiency and long-term outcomes. CRT devices support this approach by reducing repeat hospital visits and improving patient quality of life. This shift is influencing purchasing decisions and shaping the overall Cardiac resynchronization therapy market forecast.

For a more tailored understanding, view the localized Japanese edition alongside the global market breakdown -

Cardiac Resynchronization Therapy Market Segmentation

• By Device Type

• CRT-Defibrillators

• CRT-Pacemakers

• By End User

• Hospitals and Cardiac Centers

• Ambulatory Surgical Centers

• Other Healthcare Settings

• By Application

• Intraventricular Dyssynchrony

• Interventricular Dyssynchrony

• Atrioventricular Dyssynchrony

• By Technology

• Conventional Bi-Ventricular Pacing

• His-Bundle Pacing

• Left Bundle Branch Area Pacing

• By Geography

• North America

• Europe

• Asia-Pacific

• Middle East and Africa

• South America

Cardiac Resynchronization Therapy Market Key Players

• Abbott Laboratories

• Boston Scientific Corporation

• Medtronic Plc

• BIOTRONIK

• Lepu Medical Technology (Beijing) Co., Ltd.

Conclusion

The Cardiac resynchronization therapy market is expected to maintain steady progress as healthcare systems continue to prioritize effective management of heart failure. With increasing awareness, better diagnostic capabilities, and supportive healthcare policies, the adoption of CRT devices is likely to expand further.

Overall, the Cardiac resynchronization therapy market forecast remains positive, supported by consistent demand, ongoing improvements in treatment approaches, and expanding access to advanced cardiac care across both developed and emerging regions.

Industry Related Reports:

Canada Cardiovascular Devices Market

The Canada cardiovascular devices market is estimated at USD 1.81 billion in 2026, growing from USD 1.7 billion in 2025 and projected to reach USD 2.44 billion by 2031 at a CAGR of 6.18%. Growth is supported by rising cardiovascular disease prevalence, increasing adoption of minimally invasive procedures, and strong healthcare infrastructure with favorable reimbursement policies.

Cardiovascular and Soft Tissue Repair Patches Market

The cardiovascular and soft tissue repair patches market is expected to grow from USD 5.13 billion in 2025 to USD 5.55 billion in 2026, reaching USD 8.23 billion by 2031 at a CAGR of 8.18%. Expansion is driven by growing surgical procedures, increasing demand for biologic and synthetic patches, and advancements in tissue repair technologies.

Europe Cardiac Assist Devices Market

The Europe cardiac assist devices market is projected to grow at a CAGR of 7.6% during the forecast period. Growth is influenced by the rising burden of heart failure, increasing adoption of ventricular assist devices, and supportive regulatory frameworks across European healthcare systems.

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

...

MENAFN27042026003238003268ID1111039632